Gary Charles Robb - 01 Sep 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Business Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb.
Issuer symbol
CORT
Transactions as of
01 Sep 2022
Net transactions value
+$26,240
Form type
4
Filing time
06 Sep 2022, 20:59:31 UTC
Previous filing
01 Sep 2022
Next filing
08 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Award $26,240 +1,010 +1% $25.98 98,534 01 Sep 2022 Direct F1, F2
transaction CORT Common Stock Award $0 +1,010 +1% $0.000000 99,544 01 Sep 2022 Direct F3
holding CORT Common Stock 5,814 01 Sep 2022 Custodial Account for Child F4
holding CORT Common Stock 5,814 01 Sep 2022 Custodial Account for Child F4
holding CORT Common Stock 5,814 01 Sep 2022 Custodial Account for Child F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2022.
F2 In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
F3 Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements under the Purchase Plan.
F4 These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.